课题基金 / 基金详情

COMPARATIVE GENETIC TOXICOLOGY OF H.C. BLUE 1 AND H.C. BLUE 2

COMPARATIVE GENETIC TOXICOLOGY OF H.C. BLUE 1 AND H.C. BLUE 2
H.C. 的比较遗传毒理学
批准号:
3876882
负责人:
R LANGENBACH
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

R LANGENBACH的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
H.C. Blue 1 is carcinogenic in the B6 mouse liver but not in the F344 rat, whereas H.C. Blue 2 is not carcinogenic in either species. The in vivo metabolism of the chemicals in the urine of both species, and the in vitro metabolism by hepatocytes from both species, have been analyzed. In vivo metabolism and hepatocyte metabolism gave similar HPLC profiles for each chemical. Rats and mice differed quantitatively in the H.C. Blue 1 metabolite profiles produced, which may contribute to the H.C. Blue 1's species specificity. The identity of specific metabolites are currently being identified. The adduction to DNA of H.C. Blue 1 to mouse and rat liver tissue had hepatocytes has been investigated. But studies have indicated an impurity(ies) may be responsible for adduct formation and therefore H.C. Blue 1 has been subjected to HPLC purification. From these studies, an impurity in H.C. Blue 1 responsible for mutagenicity and DNA adduction in Salmonella has been isolated. Seven DNA adducts have been identified in Salmonella. Purified H.C. Blue 1 is not mutagenic and does not form DNA adducts. Studies are continuing in an attempt to elucidate the basis of H.C. Blue 1's carcinogenic activity in the mouse and lack of carcinogenic activity in the rat.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TRANSFECTION OF CDNAS FOR DRUG METABOLIZING ENZYMES
MOUSE MODEL--TARGETED GENE KNOCK-OUT OF PROSTAGLANDIN SYNTHASE I AND II
MOUSE MODEL--TARGETED GENE KNOCK OUT OF CYTOSOLIC PHOSPHOLIPASE A2
TRANSFECTION OF CDNAS FOR DRUG METABOLIZING ENZYMES
海外基金